Innocrin Pharmaceuticals Overview
- Founded
-
2014
- Status
-
Out of Business
- Employees
-
10
- Latest Deal Type
-
Out of Business
Innocrin Pharmaceuticals General Information
Description
Developer of oral inhibitors designed to treat breast and prostate cancer. The company's inhibitors help in treating castration-resistant prostate cancer and are used in other hormonally-driven conditions such as endometriosis or congenital adrenal hyperplasia, thereby enabling hospitals to treat even non-oncologic syndromes caused due to excessive androgen production.
Contact Information
Website
www.innocrinpharma.org
Formerly Known As
Hephestics, Viamet Pharmaceuticals
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Medical Supplies
Therapeutic Devices
Drug Delivery
Primary Office
- 4220 Appex Highway 55
- Suite 330
- Durham, NC 27713
- United States
+1 (919) 000-0000
Innocrin Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Out of Business | 01-Oct-2019 | 000.00 | Completed | Out of Business | ||
| 3. Later Stage VC | 13-Jul-2017 | 000 | 000.00 | Completed | Generating Revenue | |
| 2. Later Stage VC | 20-Apr-2015 | $28.1M | $28.1M | Completed | Generating Revenue | |
| 1. Accelerator/Incubator | Completed | Startup |
Innocrin Pharmaceuticals Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Financing
Details
Developer of oral inhibitors designed to treat breast and prostate cancer. The company's inhibitors help in treating cas
Drug Discovery
Durham, NC
10
As of 2016
000.00
00000000 00
000.00
000000
mco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in re
0000 00000000
Deerfield, IL
00
As of 0000
00000
0000000 0000
00000
000000
amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et
0000 000000000
Middleton, WI
00
As of 0000
000.00
0000000000 0
000.00
Add Comparison
Innocrin Pharmaceuticals Competitors (15)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Aerami Therapeutics | Private Equity-Backed | Deerfield, IL | 00 | 00000 | 0000000 0000 | 00000 |
| 00000000 | Venture Capital-Backed | Middleton, WI | 00 | 000.00 | 0000000000 0 | 000.00 |
| 00000000 00000000 | Corporate Backed or Acquired | Cary, NC | 00 | 000000&0 | ||
| 0000000000 | Venture Capital-Backed | Pittsburgh, PA | 00 | 0000 | 00000000000 | 0000 |
| 0000 00000000000 | Formerly VC-backed | Cambridge, MA | 00 | 00000 | 00000000 | 00000 |
Innocrin Pharmaceuticals Patents
Innocrin Pharmaceuticals Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-2751117-A4 | Metalloenzyme inhibitor compounds | Inactive | 30-Aug-2011 | 0000000000 | |
| EP-2751117-A2 | Metalloenzyme inhibitor compounds | Inactive | 30-Aug-2011 | 0000000000 | |
| US-9150527-B2 | Metalloenzyme inhibitor compounds | Inactive | 30-Aug-2011 | 0000000000 | |
| US-20140303157-A1 | Metalloenzyme inhibitor compounds | Active | 30-Aug-2011 | 0000000000 | |
| AU-2012300275-A1 | Metalloenzyme inhibitor compounds | Inactive | 30-Aug-2011 | C07D277/24 |
Innocrin Pharmaceuticals Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
